|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||0.21 - 0.21|
|52-week range||0.14 - 0.38|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
CAMBRIDGE, Mass., Aug. 07, 2018-- Artificial intelligence platform provider, EnvoyAI, has entered into a distribution deal with Mach7 Technologies, a leading enterprise imaging solution provider. The deal ...
BURLINGTON, Vt ., April 25, 2018 /PRNewswire/ -- Mach7 Technologies announces a business update for the quarter ended March 31, 2018 demonstrating great momentum moving toward the end of their fiscal year. ...
SirenMD harnesses the power of Sage, Mach7's Data Services Platform, to provide organized aggregated clinical data to a team of providers for seamlessly coordinated patient care. CHICAGO, Nov. 29, 2017 /PRNewswire/ -- Mach7 Technologies (M7T.AX), a global market leader in data management solutions, announced today on the RSNA exhibition floor their partnership with SirenMD for innovative product development. SirenMD is a workplace collaboration platform designed to increase the quality, efficiency, and timeliness of medical decisions by facilitating coordinated communication between caregivers and patient advocates (doctors, nurses, athletic trainers, and other medical personnel).